Zhang Q - Search Results

1

The reduction of tumor interstitial fluid pressure by liposomal imatinib and its effect on combination therapy with liposomal doxorubicin.

Fan Y, Du W, He B, Fu F, Yuan L, Wu H, Dai W, Zhang H, Wang X, Wang J, Zhang X, Zhang Q. Fan Y, et al. Among authors: zhang q, zhang h, zhang x. Biomaterials. 2013 Mar;34(9):2277-88. doi: 10.1016/j.biomaterials.2012.12.012. Epub 2013 Jan 4. Biomaterials. 2013. PMID: 23290525

2

[Study on pharmaceutical characterization and pharmacokinetics of daunorubicin long-circulating liposomes in rat].

Zhang H, Qi XR, Zhang Q. Zhang H, et al. Among authors: zhang q. Yao Xue Xue Bao. 2002 Apr;37(4):299-303. Yao Xue Xue Bao. 2002. PMID: 12579828 Chinese.

3

[Interaction between insulin with liposome].

Zhang X, Qi XR, Zhang Q. Zhang X, et al. Among authors: zhang q. Yao Xue Xue Bao. 2002 May;37(5):370-3. Yao Xue Xue Bao. 2002. PMID: 12579844 Chinese.

4

A lipid nanoparticle system improves siRNA efficacy in RPE cells and a laser-induced murine CNV model.

Liu HA, Liu YL, Ma ZZ, Wang JC, Zhang Q. Liu HA, et al. Among authors: zhang q. Invest Ophthalmol Vis Sci. 2011 Jul 1;52(7):4789-94. doi: 10.1167/iovs.10-5891. Invest Ophthalmol Vis Sci. 2011. PMID: 21519028

5

A novel nanomatrix system consisted of colloidal silica and pH-sensitive polymethylacrylate improves the oral bioavailability of fenofibrate.

Jia Z, Lin P, Xiang Y, Wang X, Wang J, Zhang X, Zhang Q. Jia Z, et al. Among authors: zhang q, zhang x. Eur J Pharm Biopharm. 2011 Sep;79(1):126-34. doi: 10.1016/j.ejpb.2011.05.009. Epub 2011 May 30. Eur J Pharm Biopharm. 2011. PMID: 21658449

6

Targeted delivery of a combination therapy consisting of combretastatin A4 and low-dose doxorubicin against tumor neovasculature.

Yang T, Wang Y, Li Z, Dai W, Yin J, Liang L, Ying X, Zhou S, Wang J, Zhang X, Zhang Q. Yang T, et al. Among authors: zhang q, zhang x. Nanomedicine. 2012 Jan;8(1):81-92. doi: 10.1016/j.nano.2011.05.003. Epub 2011 May 20. Nanomedicine. 2012. PMID: 21664295

7

Preparation of the albumin nanoparticle system loaded with both paclitaxel and sorafenib and its evaluation in vitro and in vivo.

Zhang JY, He B, Qu W, Cui Z, Wang YB, Zhang H, Wang JC, Zhang Q. Zhang JY, et al. Among authors: zhang q, zhang h. J Microencapsul. 2011;28(6):528-36. doi: 10.3109/02652048.2011.590614. Epub 2011 Jun 27. J Microencapsul. 2011. PMID: 21702701

8

Bioavailability and pharmacokinetics of sorafenib suspension, nanoparticles and nanomatrix for oral administration to rat.

Wang XQ, Fan JM, Liu YO, Zhao B, Jia ZR, Zhang Q. Wang XQ, et al. Among authors: zhang q. Int J Pharm. 2011 Oct 31;419(1-2):339-46. doi: 10.1016/j.ijpharm.2011.08.003. Epub 2011 Aug 9. Int J Pharm. 2011. PMID: 21843612

9

The eradication of breast cancer and cancer stem cells using octreotide modified paclitaxel active targeting micelles and salinomycin passive targeting micelles.

Zhang Y, Zhang H, Wang X, Wang J, Zhang X, Zhang Q. Zhang Y, et al. Among authors: zhang q, zhang h, zhang x. Biomaterials. 2012 Jan;33(2):679-91. doi: 10.1016/j.biomaterials.2011.09.072. Epub 2011 Oct 22. Biomaterials. 2012. PMID: 22019123

10

Chlorotoxin-modified stealth liposomes encapsulating levodopa for the targeting delivery against Parkinson's disease in the MPTP-induced mice model.

Xiang Y, Wu Q, Liang L, Wang X, Wang J, Zhang X, Pu X, Zhang Q. Xiang Y, et al. Among authors: zhang q, zhang x. J Drug Target. 2012 Jan;20(1):67-75. doi: 10.3109/1061186X.2011.595490. J Drug Target. 2012. PMID: 22149216

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

70,020 results

Search Page

Filters